OrbiMed Capital GP VIII LLC

Insider Reports History

Entity
Company
Location
601 Lexington Avenue, 54 Th Floor, New York, NY
Signature
/s/ Carl L. Gordon, Member of OrbiMed Asia GP IV, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by OrbiMed Capital GP VIII LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kinnate Biopharma Inc. Director, 10%+ Owner Common Stock 550K $1.24M $2.25 Feb 17, 2023 Indirect

Insider Reports Filed by OrbiMed Capital GP VIII LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNTE Kinnate Biopharma Inc. Feb 17, 2023 0 $0 3 Feb 23, 2023 Director, 10%+ Owner